Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.

NCT03921216 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT03921216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03921216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.
Lead sponsor
Karolinska University Hospital
Phase
Observational
Overall status
Suspended
Start date
April 17, 2019
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, diabetes mellitus, type 2, diabetic nephropathies